← All stocks

Outlook Therapeutics, Inc.

OTLK Net buying
CIK 0001649989 #4052 in the set updated 17 Sep 2026
Bought (120 mo)
$41.44M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.04M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$2.04M
25 of 25 sales
Net
+$39.40M
+$39.40M against sales at will

By person

23 insiders · 103 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sukhtian Ghiath M.
Director
$35.86M (4)
+$35.86M
75,582,378
$74.83M
+465.7%
Syntone Ventures LLC entity
10% owner
$4.00M (3)
+$4.00M
1,705,438
$1.69M
HILZINGER KURT J
Director
$900.95K (37)
+$900.95K
423,655
$419.42K
Dagnon Terry
Chief Operations Officer
$59.48K (3)
$785.83K (3)
−$726.36K
653,058
$646.53K
Evanson Jeff
CHIEF COMMERCIAL OFFICER
$73.41K (2)
$663.24K (6)
−$589.83K
808,459
$800.37K
Mohan Pankaj
Director
$5.44K (1)
$253.39K (4)
−$247.95K
7,683,667
$7.61M
−2.7%
Sukhtian Faisal Ghiath
Director
$238.83K (6)
+$238.83K
56,037,758
$55.48M
+101.8%
Haddadin Yezan Munther
Director
$143.63K (8)
+$143.63K
66,167
$65.51K
Gangloff Scott A.
SVP, Development & Mfrg
$140.13K (1)
−$140.13K
118,573
$117.39K
+2.3%
MCANDREW STEPHEN J
SVP Bus. Strat. & Dev.
$97.87K (2)
−$97.87K
50,899
$50.39K
+91.6%
TRENARY C RUSSELL III
CEO AND PRESIDENT
$69.87K (3)
+$69.87K
54,925
$54.38K
Bahrt Kenneth
Chief Medical Officer
$36.07K (2)
−$36.07K
47,120
$46.65K
KENYON LAWRENCE A
Chief Financial Officer
$69.13K (4)
$40.67K (3)
+$28.46K
106,956
$105.89K
Yamashita Elizabeth A.
VP, Regulatory Affairs
$27.05K (3)
−$27.05K
64,648
$64.00K
+48.7%
THURMAN RANDY H
Director
$18.60K (3)
+$18.60K
5,593
$5.54K
Griffith Donald J.
Director
$3.75 (1)
−$3.75
144,926
$143.48K
0.0%
Jahr Robert Charles
Chief Executive Officer
(1)
$0.00
151,515
$150.00K
BioLexis Pte Ltd. entity
10% owner
25,443,159
$25.19M
Pillai Arun Kumar
Director
22,982,529
$22.75M
−9.8%
Canute Scott A
Director
246,342
$243.88K
+30.4%
Brady Todd C
Director
153,288
$151.76K
0.0%
Bao Kogan
VP, Analytical Sciences
71,739
$71.02K
+230.0%
Smith Hoke Robin
Director
1,939
$1.92K

No percentages here. This company's share count has moved by a factor of 9.8 over the window, from 24,905,635 to 243,447,554 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
BioLexis Pte Ltd.
29 Jan 2020
Director
Exercised, kept
4,657,852
$0.23
$1.08M
BioLexis Pte Ltd.
23 Dec 2019
Director
Exercised, kept
2,909,091
$0.23
$674.91K
HILZINGER KURT J
23 Jan 2017
Director
Exercised, kept
12,036
$0.01
$120.36

What was left out

Form 4 filings counted 262
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 30
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 25
Transactions with no price 3
Shares from compensation/vesting 197,356,817
Sales filed before the plan box existed 24
History held since 14 Nov 2016